Enzyme Finance Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Enzyme Finance General Information
Description
Developer of blockchain software designed to assist asset managers. The company offers an autonomous system that has both its frontend and its backend hosted and executed on decentralized platforms, thereby replacing a large proportion of the middlemen with smart contracts, enabling asset managers to perform the same tasks at a fraction of the cost and with higher transparency, security, and minimized requirement for trust.
Contact Information
Website
www.enzyme.financeCorporate Office
- Zug
- Switzerland
Corporate Office
- Zug
- Switzerland
Enzyme Finance Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 1. Later Stage VC | 01-Jan-2022 | Completed | Generating Revenue |
Enzyme Finance Comparisons
Industry
Financing
Details
Enzyme Finance Competitors (1)
One of Enzyme Finance’s competitors is Iconomi, a Venture Capital-Backed company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Iconomi | Venture Capital-Backed | London, United Kingdom |
Enzyme Finance Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Enzyme Finance Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Enzyme Finance Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Collab+Currency | Venture Capital | Minority | ||
| DeFiance Capital | Venture Capital | Minority | ||
| Iconium Blockchain Ventures | Venture Capital | Minority | ||
| Placeholder Venture Capital | Venture Capital | Minority |
Enzyme Finance Investments & Acquisitions (2)
Enzyme Finance’s most recent deal was a Early Stage VC with Neutral Trade for . The deal was made on 01-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Neutral Trade | 01-Jun-2025 | Early Stage VC | Software Development Applications | ||
| Myso Finance | 04-Sep-2024 | Merger/Acquisition | Financial Software |
Enzyme Finance FAQs
-
When was Enzyme Finance founded?
Enzyme Finance was founded in 2017.
-
Where is Enzyme Finance headquartered?
Enzyme Finance is headquartered in Zug, Switzerland.
-
What is the size of Enzyme Finance?
Enzyme Finance has 15 total employees.
-
What industry is Enzyme Finance in?
Enzyme Finance’s primary industry is Financial Software.
-
Is Enzyme Finance a private or public company?
Enzyme Finance is a Private company.
-
What is Enzyme Finance’s current revenue?
The current revenue for Enzyme Finance is .
-
Who are Enzyme Finance’s investors?
Collab+Currency, DeFiance Capital, Iconium Blockchain Ventures, and Placeholder Venture Capital have invested in Enzyme Finance.
-
Who are Enzyme Finance’s competitors?
Iconomi is a competitor of Enzyme Finance.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
